Moreover, the CCR7 chemokine axis, which encompasses CCL21 and CCL19, has emerged as a promising target for cancer immunotherapy, demonstrating potential as a target for therapeutic intervention [54, 55]. The gene discussed is CCR7; the disease is cancer.